Accorsi 2020 |
Ineligible population |
Afshar 2020 |
Ineligible design |
Agarwal 2021 |
Ineligible design |
Ai 2020 |
Preprint |
Akinbami 2021 |
Ineligible population |
Akyala 2020 |
Ineligible population |
Aleebrahim‐Dehkordi 2020 |
Conference abstract |
Al‐Rifai 2021 |
Only SARS‐CoV‐2‐positive patients |
Altınbilek 2020 |
Ineligible outcomes |
Andina‐Martinez 2021 |
Only SARS‐CoV‐2‐positive patients |
Antonelli 2021 |
Index test not assessed on admission |
Aubert 2021 |
Ineligible design |
Auvinen 2021 |
Ineligible population |
Baghaei 2020 |
Ineligible outcomes |
Bailey 2020 |
No data |
Bailey 2021 |
Ineligible outcomes |
Bartlett 2020 |
Conference abstract |
Bastiani 2021 |
Ineligible design |
Bhatta 2021 |
Only SARS‐CoV‐2‐positive patients |
Bidkar 2021 |
Ineligible population |
Bonadio 2020 |
Conference abstract |
Brotons 2020 |
Preprint |
Burrel 2021 |
Ineligible outcomes |
Cadegiani 2021 |
Ineligible design |
Cai 2020 |
Timing of index test not specified |
Calagnan 2020 |
Ineligible design |
Carignan 2020 |
Ineligible design |
Challener 2020 |
Ineligible design |
Chen 2020 |
Ineligible design |
Chen 2021 |
Ineligible population |
Concheiro‐Guisan 2020 |
Index test not assessed on admission |
D'Souza 2020 |
No clinical suspicion at inclusion |
Dai 2021 |
Timing of index test not specified |
Dantas 2021 |
Ineligible population |
De Angelis 2020 |
Ineligible population |
Deng 2020 |
Ineligible population |
Dixon 2021 |
Index test not assessed on admission |
Dreyer 2020 |
Ineligible population |
Duan 2020 |
No data |
Duque 2021 |
Ineligible design |
Duramaz 2021 |
Only SARS‐CoV‐2‐positive patients |
Elimian 2020 |
Timing of index test not specified |
Escosteguy 2020 |
Ineligible population |
Feehan 2021 |
Ineligible population |
Fisher 2021 |
Index test not assessed on admission |
Foster 2021 |
Ineligible design |
Gale 2020 |
Ineligible population |
Gerkin 2021 |
Ineligible design |
Giavedoni 2020 |
Only SARS‐CoV‐2‐positive patients |
Gibbons 2021 |
Index test not assessed on admission |
Gnanasambantham 2020 |
Ineligible design |
Goel 2020 |
Ineligible index test |
Gombos 2021 |
No data |
Goodacre 2020 |
Ineligible population |
Guillén 2020 |
Only SARS‐CoV‐2‐positive patients |
Gurrola 2021 |
Only SARS‐CoV‐2‐positive patients |
Haddadin 2021 |
Ineligible population |
Hamed 2021 |
Ineligible design |
Hernández‐Cruz 2021 |
Ineligible population |
Hosseinzadeh 2021 |
Ineligible design |
Hosseninasab 2020 |
Timing of index test not specified |
Hubiche 2021 |
Conference abstract |
Hurst 2020 |
No data |
Indini 2021 |
Ineligible population |
Islam 2020 |
Conference abstract |
Jain 2021 |
Case report |
Karni 2020 |
Ineligible design |
Kasiukiewicz 2020 |
Conference abstract |
Kline 2021 |
Ineligible design |
Lechner 2021 |
Ineligible design |
Lee 2020 |
Ineligible design |
Lee 2021 |
Only SARS‐CoV‐2‐positive patients |
Li 2020a |
Timing of index test not specified |
Li 2020b |
Timing of index test not specified |
Li 2021 |
Ineligible outcomes |
Liang 2020 |
Preprint |
Liu 2021 |
Ineligible design |
Loftus 2020 |
Index test not assessed on admission |
Lu 2020 |
Ineligible population |
Madan 2020 |
Ineligible design |
Makaronidis 2020 |
Ineligible population |
Manley 2020 |
Conference abstract |
McDonald 2020 |
Ineligible design |
McGovern 2020 |
Conference abstract |
Medetalibeyoglu 2020 |
Conference abstract |
Membrilla 2020 |
Only SARS‐CoV‐2‐positive patients |
Mizrahi 2020 |
Ineligible design |
Möckel 2021 |
Ineligible design |
Moolla 2021 |
Index test not assessed on admission |
Muhammad 2021 |
Ineligible design |
Munblit 2020 |
Only SARS‐CoV‐2‐positive patients |
Murillo‐Zamora 2020 |
Ineligible index test |
Nakajima 2021 |
Ineligible design |
Nakanishi 2020 |
Ineligible design |
Nayan 2021 |
No data |
Nobel 2020 |
Ineligible design |
Ortiz 2020 |
Only SARS‐CoV‐2‐positive patients |
Oshman 2020 |
Ineligible outcomes |
Ozcan 2021 |
No data |
Paar 2021 |
Ineligible population |
Pigott 2020 |
Conference abstract |
Platten 2021 |
No clinical suspicion at inclusion |
Popovych 2021 |
Ineligible population |
Pullen 2020 |
Ineligible design |
Quer 2020 |
Ineligible design |
Ravani 2020 |
No clinical suspicion at inclusion |
Rentsch 2020 |
Preprint |
Ronan 2021 |
No data |
Rubel 2020 |
Index test not assessed on admission |
Sabetian 2021 |
Only SARS‐CoV‐2‐positive patients |
Sabetta 2020 |
Ineligible outcomes |
Sehanobish 2021 |
Index test not assessed on admission |
Senok 2020 |
Ineligible design |
Shanbehzadeh 2021 |
Ineligible design |
Shayganmehr 2021 |
Ineligible population |
Sheen 2020 |
No data |
Shoer 2021 |
No clinical suspicion at inclusion |
Sieber 2021 |
Ineligible population |
Song 2020 |
Preprint |
Sorlini 2020 |
Ineligible design |
Spangler 2021 |
Ineligible outcomes |
Stacevičienė 2021 |
Ineligible design |
Tabacof 2020 |
Only SARS‐CoV‐2‐positive patients |
Taziki 2020 |
Index test not assessed on admission |
Ticinesi 2020 |
Conference abstract |
Trevisan 2021 |
Ineligible design |
Verma 2020 |
Index test not assessed on admission |
Viana dos Santos 2021 |
Ineligible design |
Visconti 2021 |
Ineligible design |
Vos 2020 |
Ineligible design |
Weiss 2021a |
Ineligible design |
Weiss 2021b |
Ineligible population |
Wells 2020 |
No clinical suspicion at inclusion |
Wu 2020 |
Only SARS‐CoV‐2‐positive patients |
Xia 2021 |
Ineligible population |
Yan 2020 |
Ineligible design |
Yang 2020 |
Preprint |
Yousef 2021 |
Ineligible design |
Žaja 2021 |
Only SARS‐CoV‐2‐positive patients |
Zavascki 2020 |
Preprint |
Zayet 2020b |
Ineligible design |
Zhao 2020 |
Ineligible design |
Zhao 2021 |
Ineligible design |